Bioequivalence and Bioavailability Forum

Subject	Category	Author	Posted	Rep.	last R.	Views
Chile regulatory	Regulatives / Guidelines	Pharma_88	2023-05-10 04:19	0		2,015
Sample size estimation for parallel design Parallel designs (total variance) Parallel designs (total variance) CV-intra # 60% CV-inter total (pooled) variance: examples total (pooled) variance: examples total (pooled) variance: examples Higher-Order Crossovers Higher-Order Crossovers total (pooled) variance: examples total (pooled) variance: examples total (pooled) variance: examples total (pooled) variance: examples total (pooled) variance: examples total (pooled) variance: examples Sample size estimation for parallel design	Power / Sample Size	Nav Coelho	2007-07-20 16:14	15	2023-05-04 08:17	30,989
ABE results from SAS and WinNolin are not matched ABE results from SAS and WinNolin are not matched Variable names, lexical order? Variable names, lexical order? Variable names, lexical order? Variable names, lexical order?	Regulatives / Guidelines	weiguo2122	2023-04-19 14:43	5	2023-04-21 15:45	4,335
Definition of Full Replicate Definition of Full Replicate Definition of Full Replicate Definition of Full Replicate Definition of Full Replicate Full Replicate with 3 periods Full Replicate with 3 periods Full Replicate with 3 periods Definition of Full Replicate Replicate Design ≠ Higher-Order Crossover Thank You! Replicate Design ≠ Higher-Order Crossover imbalance in Latin Square Balance for all effects	Design Issues	Sereng	2023-03-13 17:08	13	2023-04-21 10:01	6,821
Chili guidelines ANAMED ANAMED	Regulatives / Guidelines	gsrao2022	2022-12-25 16:17	2	2023-04-19 04:57	6,398
Oxcarbazepine Tablet Fasting and Fed	Regulatives / Guidelines	AB661	2023-04-15 07:47	0		1,997
FDA draft guidance on transdermal systems	BE/BA News	Ohlbe	2023-04-13 08:37	0		2,401
CI.BE in PowerTOST Bug in PowerTOST:CI.BE Bug in PowerTOST:CI.BE	🇷 for BE/BA	BEQool	2023-03-31 10:05	2	2023-04-03 05:38	4,177
New guidance on Statistical Approaches to Establishing Bioequivalence A first look A first look A first look SAS strikes back SAS strikes back Outliers? Outliers? SAS strikes back model-based BE? model-based BE? Hooker, Moellenhoff et al. are moving MBBE forward model-based BE? A first look A first look Groups, sites… SxF SxF New guidance on Statistical Approaches to Establishing Bioequivalence Webinar: A Deep Dive: FDA Draft Guidance on Statistical Approaches to Establishing Bioequivalence Webinar: A Deep Dive: FDA Draft Guidance on Statistical Approaches to Establishing Bioequivalence Multi-group studies ad nauseam Multi-group studies ad nauseam Webinar: Recording available Speed kills	BE/BA News	Relaxation	2022-12-02 15:53	24	2023-04-01 10:38	14,854
where can I find Old FDA PSG where can I find Old FDA PSG where can I find Old FDA PSG	Regulatives / Guidelines	Achievwin	2023-03-24 14:51	2	2023-03-27 02:10	3,319
UK/EU IMP Labelling requirement for Comparator used in BE studies UK/EU IMP Labelling requirement for Comparator used in BE studies	Regulatives / Guidelines	HallaGulla	2023-03-22 12:34	1	2023-03-24 13:59	3,331
Upper confidence bound and confidence interval of RSABE	RSABE / ABEL	WinnieH	2023-03-21 10:58	0		2,281
average bioequivalence: MLE vs. REML average bioequivalence: MLE vs. REML average bioequivalence: MLE vs. REML average bioequivalence: MLE vs. REML	General Statistics	Mahmoud	2023-03-11 12:21	3	2023-03-16 23:51	4,482
EUFEPS Open Forum: ICH M13 Draft Guideline ICH M13 Draft Guideline: FDA webinar	Conferences / Workshops	Helmut	2023-03-05 12:50	1	2023-03-15 11:42	4,473
Pumas AI: new software for Pharmacokinetic Modeling Pumas AI Pumas AI Pumas AI	Software	Rayhope	2023-03-03 05:09	3	2023-03-14 20:55	4,141